The variability in the age of tumour-onset among relatives harbouring the same germline TP53 variant clearly shows that the penetrance also depends from modifier factors that can be either genetic or environmental and their identification in the future would allow a more personalized clinical management of TP53 variant carriers. The gene discussed is TP53; the disease is neoplasm.